Most natural odors are complex mixtures of many volatile components, competing to bind odorant receptors (ORs) expressed in olfactory sensory neurons (OSNs) of the nose. To date surprisingly little is known about how OR antagonism shapes neuronal representations in the periphery of the olfactory system. Here, we investigated its prevalence, the degree to which it disrupts OR ensemble activity, and its conservation across related ORs. Calcium imaging microscopy of dissociated OSNs revealed significant inhibition, often complete attenuation, of responses to indole, a commonly occurring volatile associated with both floral and fecal odors, by a set of 36 tested odorants. To confirm an OR mechanism for the observed inhibition, we performed single-cell transcriptomics on OSNs that exhibited specific response profiles to a diagnostic panel of odorants and identified the receptor Olfr743 which, when tested in vitro, recapitulated ex vivo responses. We screened ten ORs from the Olfr743 clade with 800 perfumery-related odorants spanning a range of chemical scaffolds and functional groups, over half of which (430) antagonized at least one of the ten ORs. Furthermore, OR activity outcomes were divergent rather than redundant, even for the most closely related paralogs. OR activity fitted a mathematical model of competitive receptor binding and suggests that normalization of OSN ensemble responses to odorant mixtures is the rule rather than the exception. In summary, we observed OR antagonism, inverse agonism and partial agonism occurring frequently and in a combinatorial manner. Thus, extensive receptor-mediated computation of mixture information appears to occur in the olfactory epithelium prior to transmission of odor information to the olfactory bulb. 2 3 heterologous expression systems and the lack of a protein structure [41] have impeded systematic exploration of the full range of possible receptor-ligand interactions for ORs. As such, it is not well understood to what extent classical GPCR interactions, like antagonism, partial agonism and inverse agonism shape odor representations before they are propagated to the olfactory bulb.
INTRODUCTION
An organism's survival depends, in part, upon its ability to detect and respond to dynamic environments to locate valuable resources, avoid danger, or evaluate conspecific social cues.
On land, volatile odorants represent one particularly rich source of information about environmental context, but understanding how this information is detected and processed is challenging. First, estimates of the actual number of odors humans can distinguish are controversial, and have so far resisted reliable empirical determination [1] [2] [3] [4] [5] . Compounding this, the chemical diversity of odorant space is extensive and difficult to quantify [6] [7] [8] [9] , and the complexity of natural odors is also typically high. The same source can exhibit a range of compositions, with component concentrations varying considerably [10, 11] . Additionally, the same component can occur in diverse sources. An example of this is indole, used as a target of this study, which occurs in both fecal [12] and floral sources -it can elicit perceptual qualities reminiscent of both and is widely used in perfumery [13] .
In terrestrial mammals (including humans), the task of parsing this stimulus complexity is initiated at the periphery of the olfactory system. Volatile compounds interact with between ~200-2000 odorant receptors (ORs), depending on the mammal, which are expressed monogenically and monoallelically in olfactory sensory neurons (OSNs) lying in the nasal cavity [4, [14] [15] [16] . Demonstration of the combinatorial nature of odor encoding [17] [18] [19] [20] appeared to explain how such diverse stimuli could be detected and discriminated by the olfactory system.
That is, a single OR can be activated by a range of odorants, and a single odorant can activate multiple ORs [21] [22] [23] [24] [25] [26] [27] [28] , potentially leading to unique combinations of active ORs for a large number of possible stimuli. However, even with combinatorial encoding and a large family of receptors, recent theoretical work has suggested that OR antagonism may be required to prevent saturation of the peripheral olfactory system and retain discriminatory ability even for modestly complex odors (>20 components) [29] .
Since ORs are a large family of class A G protein-coupled receptors (GPCRs), and classic pharmacological experiments on other class A members have revealed disruption of agonist activity via competitive antagonism at the orthosteric site [30] [31] [32] , it seems likely that ORs would be similarly affected. Indeed, OR antagonism by odorants has been observed experimentally for a relatively small number of mammalian ORs [33] [34] [35] [36] [37] [38] , and has been projected to play an important role in how odorant mixtures may be encoded [39, 40] . Yet limitations in functional
Identification of Olfr743, an indole-sensitive odorant receptor
To directly link OSN inhibition to antagonism of specific olfactory receptors, we sought to identify and characterize mouse ORs conferring the observed OSN indole responses. We recorded individual OSNs responsive to sequential stimulation with 50 µM indole and several indolerelated compounds (3-methylindole, 2-methoxynaphthalene, 6-methylindole, para-cresol; Figure   4A -B). We then isolated cells with high sensitivities to indole for subsequent transcriptome analyses using a single-cell RNA-seq approach. From these analyses several phylogenetically related mouse ORs (Olfr743, Olfr740 and Olfr746) were identified independently. For example, Olfr743 was expressed in two OSNs with similar response profiles (Figure 4 A-B ). In all isolated single cells, a single OR transcript was detected at high expression levels, consistent with monogenic OR expression in OSNs [14] [15] [16] 18] (Figure 4C -D). The expression of olfactory specific markers, including OMP, G olf , Adcy3, Cnga2 and Rtp1, confirmed each cell was a mature OSN ( Figure 4C and 4D insets).
We then characterized the activation profile of Olfr743 by performing dose-response experiments in a functional heterologous expression system with the same compounds used to characterize the OSNs of origin. We used an immuno-competitive cAMP binding assay and measured the receptor's specificity (the molecular receptive range within the confines of our library), and odorants' potency (sensitivity to a particular ligand or EC 50 ) and efficacy (the extent of activation between no binding and full saturation of the receptor). With this approach, the recorded signal is inversely proportional to the concentration of cAMP produced upon ligand binding. The response of Olfr743 to these compounds varied in potency and in efficacy (maximum HTRF ratio) ( Figure 4E ). Importantly, the compound response rank-order was largely consistent with that of peak heights (used as a proxy for OSN sensitivity) in the OSN responses.
Overall, these results suggest that Olfr743 is directly responsible for the observed OSN responses, and provide an effective method to deorphan ORs based on complex response profiles [46] .
Characterization of an indole-responsive odorant receptor gene family
Because distinct OSN response profiles indicated that more than one OR could respond to indole (Figures 3 and S3 ), we extended the search for indole-sensitive ORs to a seven-member 7 paralogous gene family with greater than 78% amino acid identity to Olfr743. In addition to this first group, we also selected an additional set of five receptor genes with greater than 55% identity, defining a less conserved phylogenetic outgroup ( Figure S4 ). We first tested the response of the 12 receptors to increasing doses of indole and structurally-related compounds ( Figures 4F and S5 ). All paralogs except Olfr745 were activated by all of the indole-related odorants except Lilyflore®. Although the receptors showed similar and partially overlapping activation profiles, potency varied widely among receptors for a given ligand, in some cases spanning several orders of magnitude. For example, indole EC 50 s obtained from complete doseresponse curves ranged between nanomolar and micromolar concentrations (80 nM for Olfr743 to 81 µM for Olfr748). Even among paralogous ORs sharing almost 80% identity, indole's EC 50 still varied by more than two orders of magnitude (from 80 nM for Olfr743 to 32 µM for Olfr739).
Response efficacy also varied, encompassing inverse, partial and full agonism. 2methoxynaphthalene partially activated Olfr738, Olfr739, Olfr740, and Olfr744, (71-75% of the maximum indole response) and fully activated Olfr741, Olfr742, and Olfr743. Similarly, Lilyflore® displayed no, partial and full agonism across the tested ORs, even eliciting clear inverse agonism on Olfr740, Olfr743 and Olfr744, indicating that the latter three receptors were constitutively active in our assay ( Figure S5 ). Thus, even across this small set of ligands, these closely related ORs displayed diverse agonist profiles, and, moreover, displayed receptor binding outcomes not confined to full agonism; namely partial and inverse agonism.
Functional diversity of the Olfr743 family
We examined the range of functional responses for this family by performing singleconcentration agonist and antagonist screens using ~800 distinct stimuli for the 10 ORs which displayed a full indole-dose response ( Figure S5 ). These compounds consisted of 640 aromatic and 282 aliphatic compounds, covering 195 combinations of various chemical features ( Figure   S6 ). Agonism was assessed by stimulating each OR with 300 µM of each compound, while antagonism was assessed by measuring the change in receptor activation elicited by 300 µM of each compound in the presence of the EC 80 of indole for each OR. We then chose the top 5 antagonists or agonists for each OR and tested these compounds against all 10 ORs in doseresponse experiments in the presence (for antagonists) or absence (for agonists) of the EC 80 of indole. Using these data, we constructed receiver operating characteristic (ROC) curves for each screen. The area under the curve (AUC) for the antagonist screen was 0.78, p < 0.0001; 8 AUC for the agonist screen was 0.90, p < 0.0001; ( Figure S7 ). From this analysis, 75% of true antagonists showed inhibition greater than 24% in single-concentration antagonist screens and 80% of true agonists showed activation greater than 32% in single-concentration agonist screens.
Using these cutoff values, we then examined the number of antagonists and agonists for each OR and the overlap among related family members. We identified a total of 430 antagonists and 444 agonists that elicited a response in at least one OR, i.e. over half the tested library for both screens ( Figure 5 and S8). The number of antagonists and agonists varied widely and tended to be inversely correlated. For example, Olfr746 had 30 antagonists and over 400 agonists, while Olfr740 had the greatest number of antagonists (352) and the lowest number of agonists (28) ( Figure 5A ). We used an Upset plot [47] to examine the number of unique antagonists and agonists for each OR as well as the overlap among ORs ( Figures 5B and S8A ). Of the 430 antagonists, Olfr740 had both the largest number of total and unique antagonists (149). Olfr746 had both the largest number of total and unique agonists (187).
Many of the compounds tested were ligands for multiple Olfr743 family members -281 were antagonists, and 257 agonists for more than one of the tested ORs. For OR pairs with greater than 90% identity, the average frequency of overlap was 0.70 for inhibitors and 0.86 for activators, yet we observed variation in this frequency. For some closely-related pairs of receptors, the number of overlapping compounds reflected their degree of relatedness. For example, Olfr741 and Olfr742, which have 94% amino acid identity, shared 75% of their antagonists and 100% of their agonists (i.e. all Olfr742 agonists also activated Olfr741). For some receptor pairs, however, the number of antagonists or agonists shared between two ORs was less reflective of their similarity. Olfr739 is 90% identical to Olfr742 and shares only 60% of its antagonists and 67% of its agonists.
To further compare the functional responses of this OR family, we constructed Pearson correlation matrices for the antagonist ( Figure 5C ) and agonist ( Figure S8B ) screening values for each pair of ORs. Hierarchical clustering of the correlation matrices recapitulated phylogenetic proximity for both screens; however, the median correlation values were moderate (r median is ~0.5 for both assays) and varied extensively, indicating high, but widely variable functional diversification ( Figure S8C ). As shown in Figure 5C , Olfr741 and Olfr742 were highly correlated in both their inhibition and their activation profiles (r median ~0.70 for both assays), 9 whereas, Olfr739 and Olfr742 were much less well-correlated (r median ~0.4 for both inhibition and activation) despite sharing 94% and 90% amino acid identities, respectively. In fact, an OR pair with relatively low identity, Olfr738 and Olfr749 (~60%), was better correlated for both activation (r = 0.72) and inhibition (r = 0.63) than Olfr739 and Olfr742. When compared directly ( Figure   5D ), the correlation between percent amino acid identity and functional similarity (as measured by the pairwise OR Pearson correlation values) reflected a high degree of functional divergence with statistically significant (p < 0.001 for inhibition and p < 0.0001 for activation), but low positive correlations (r = 0.50 for inhibition, r = 0.63 for activation). Furthermore, when analyzed by calculating Jaccard indices over the sets of ligands ( Figure S9 , Methods), the agonists and antagonists again showed very similar distributions of values, but were less conserved, on average, than binding was. These results indicate that phylogenetic similarity is not always indicative of functional similarity, and vice versa. Also implied, is that as ORs diversify over evolutionary time, binding outcomes (i.e. agonism and antagonism) over a set of odorants diversify more rapidly than the ability to bind them.
Widespread and diversifying antagonism of related ORs
To further explore the diversity of functional outcomes among these paralogous ORs, we measured their activation (EC 50 ), and inhibition dose-response profiles (relative IC 50 in the presence of a potent concentration of indole, EC 80 ), for the top five antagonists for each OR as well as indole and Lilyflore® ( Figure 6A ). The 37 compounds tested in this way can be seen to span a range of chemical scaffolds, including 5,6-and 6,6-bicyclic aromatics, macrocycles and polycycles, aliphatic chains, and multiple functional group including alcohols, ketones, acids, lactones and esters. A composite heat map including both measurements summarizes the diversity of outcomes we observed ( Figure 6B ). The IC 50 rank-order of the top five antagonists selected for each receptor was consistent when compared to the single-concentration inhibition modulation values. All 37 compounds inhibited more than one receptor (c.f. Figure 5 ), consistent with the high frequency of antagonism previously observed. Compounds #1, #10, #11 and #42-45 inhibited all receptors despite sequence identities as low as 56% between Olfr746 and Olfr741 ( Figure 6B and S4). As in Figure 4 , indole again activated all of these ORs. Almost half of the compounds (16, 44%) showed divergent outcomes at the concentrations tested, ranging from strong inhibition to potent activation. This was also observed for the closest paralogs.
Olfr741 and Olfr742, with 94% sequence identity and greater than 0.70 correlation in antagonist and agonist responses, showed qualitatively different outcomes for six compounds (#47 and #59 inhibiting only Olfr742; #52, #56, #63 displaying opposite outcomes). Similarly, Olfr741 and Olfr743, which displayed the highest correlation in antagonist and agonist response (r = 0.94 for both assays), showed a divergent response to six compounds (#20, #54 and #64 inhibiting only Olfr742; #53 activating only Olfr741; #52 displaying opposite outcome). Finally, as an example of a receptor pair that is highly genetically similar but not functionally so, Olfr742 and Olfr739 differed in their response to nine of the tested compounds. As with single-concentration screening values, hierarchical clustering of similarity in OR response profile across the 37 compounds again largely reflected phylogenetic clustering ( Figure 6B , top). However, full doseresponse experiments revealed extensive functional divergence even in cases where correlations between single-concentration screening responses indicated a high level of functional similarity. Taken together, these data support the results obtained from the singleconcentration screening and their associated implications of widespread, dose-dependent antagonism and its role in functional diversification even among paralogous receptors.
Binding affinity is weakly correlated with functional outcome
Mathematical models suggest that the correlation between binding affinity and activation efficacy plays an important role in odor identification and discrimination, assuming mixture interactions are primarily due to competitive binding at the receptor level [29, [48] [49] [50] . In short, if the binding affinity and activation efficacy (i.e. ability to induce OR downstream signaling once bound) are largely uncorrelated, agonism and antagonism across the receptor ensemble are balanced. This reduces the chances of saturating the receptor repertoire in the presence of complex odor mixtures and may allow for greatly improved odor segmentation and discrimination.
In order to quantitatively test whether antagonism is indeed mediated through competition for receptor binding between the activator and inhibitor, we performed a competitive binding assay for Olfr740 with indole as the activator and compounds #10 and #1 as the inhibitors, with both agonist and antagonists varied over a range of concentrations. The data was fit to a two-step competitive binding (CB) model ( Figure 7A , Methods), where the activator and inhibitor compete to bind to the receptor with binding affinities κ -1 act and κ -1 inh respectively. The bound compound then activates the receptor with an activation efficacy η act or η inh , depending on whether the activator or inhibitor is bound. The model constrains the activation efficacy to lie between 0 and 1, where 1 represents a perfect agonist i.e., the compound fully activates the receptor whereas 0 represents no activation. To explain the cases of inverse agonism observed in the dataset, we added the possibility for spontaneous activation of the receptor which introduces constitutive activity η s (between 0 and 1) for the receptor when no compound is bound. The key parameter that determines a compound's functional outcome is its activation efficacy. A compound is a partial agonist if its activation efficacy η is less than 1 but greater than η s , and is an inverse agonist if η is less than η s . If η act > η inh and c act /κ act < c inh /κ inh , then the inhibitor 'antagonizes' the activator. The model yields an excellent fit to the data for the two inhibitors tested ( Figure 7B ), using three parameters: the binding affinities of the activator and inhibitor, κ -1 act and κ -1 inh and the ratio of the subtracted activation efficacies (η inh -η s )/(η act -η s ) (Methods).
To measure the correlation between binding affinity and activation efficacy, we fit the competitive binding model to the activation and inhibition profiles of 39 unique compounds for each of the ten ORs in the Olfr743 family, where the activator indole was delivered at EC 80, as before. The distribution of ln κ -1 (n = 199) was found to be close to a normal distribution (mean = 10.76 ~ 20 µM in concentration, SD = 1.37) with a few sensitive outliers ( Figure 7C ). We found a weak correlation between the binding affinity of activators (η ≈ 1, n act = 50) and inhibitors (η ≈ 0, n inh = 149) of ρ = 0.18 ± 0.03 (mean ± SD), where ρ is the Pearson correlation coefficient between ln κ 1 and η ( Figure 7D ). To test whether the measured statistics lead to the receptor activity normalization predicted in theory [29], we numerically computed the extent of saturation of a receptor ensemble with increasing mixture complexity, where mixture interactions were modeled using the competitive binding model and the receptor-ligand binding and activation parameters were drawn from the experimentally measured distributions ( Figure 7E ). The fraction of activated receptors (sparsity) indeed increased at a slower rate compared to any additive model of mixture interactions (ρ = 1), reaching 90% saturation for > 100 ligands compared to ≈25 for an additive model. Thus, competitive binding appeared to account for the widespread antagonism observed. Binding affinity and activation efficacy appeared largely decoupled (ρ~0.18) and these statistics would result in a meaningful expansion of the encoding capacity of the system compared to one in which antagonism was rare (ρ1) ( Figure 7E ).
DISCUSSION
Natural odors in the environment are typically mixtures of many different chemicals, yet the precise mechanisms by which complex mixtures are encoded by the odorant receptor repertoire are yet to be elucidated. In particular, the role of OR antagonism in this regard has lacked extensive empirical characterization, which formed the primary focus of the current study. We found evidence for the involvement of the full spectrum of competitive, non-cooperative, GPCR interactions in a way that was not especially biased towards agonism.
Indole was chosen as a target for antagonism throughout the study as an example of an interesting, but presumably not unique, molecule. It occurs in nature, is present at substantial levels in some flowers, and is used regularly in perfumes [13] . It is also present in latrine headspaces [12] and is reminiscent of feces if delivered at high concentrations. We found that indole and other structurally related odorants robustly and dose-dependently activated different subsets of ex vivo mouse OSNs. However, one of the ingredients tested (Lilyflore® - Figure S2) showed minimal activation overlap, despite sharing a similar 6,5-bicyclic ring structure. We thus hypothesized that Lilyflore® may still bind indole OSNs, but instead inhibit their activity. Indeed, this was the case not just for Lilyflore®, and additional structurally related compounds, but other common perfumery ingredients with varied chemical structures as well. For many odorants, complete OSN inhibition affected a large subset of the OSN population. Inhibition was much more common than the lack thereof, even considering the relatively small selection of compounds tested.
Given this finding, it was necessary to show that the OSN inhibition was indeed mediated by antagonism of indole-responsive ORs and to systematically explore its prevalence. Sampling >10,000 murine OSNs with up to 30 odorant presentations, we characterized the heterogeneous indole activation code, finding it could be partially deconstructed by examining the activation overlap between indole and five structurally related analogues. Using this panel, we identified 17 specific activation profiles within the indole-responsive OSN population, allowing us to subsequently probe the specificity of OSN response inhibition for three of the inhibitors. While these 17 groups are expected to largely segregate different OSN types (i.e.
OSNs each expressing different ORs), it was, however, not possible to use this technique to definitively relate inhibitor specificity to specific OSN types present in the indole-responsive population. This is because group mis-assignment of OSN types can occur due to the 13 concurrent presence of several factors, including variation in sensitivity of OSNs of the same type and the relatively small number of diagnostic ligands used. For example, in comparing the in vitro responses of the identified OR family to the ex vivo responses, most of the ORs were consistent with only a small subset of the OSN groups (i.e. the majority were consistent with groups 16 and 17, while Olfr745 was most similar to group 10, in Figure 4B ). Nonetheless, this approach provided a powerful way to observe the specificity of inhibition by different ligands, which when coupled with their sigmoidal dose-dependence, provided strong evidence for widespread OR antagonism.
To further explore the prevalence of antagonism for specific ORs expressed in these characterized OSNs, we devised a single-cell RNASeq-based OR identification method.
Although we did not exhaustively retrieve the ORs of all indole-responsive OSN groups, we identified an indole-sensitive OR gene family that was amenable to in vitro characterization.
Most ORs in the family were functionally expressed and responded to most of the indole analogues used for OSN characterization, albeit at various ranges of potencies and efficacies.
Olfr745 was the only exception, as it showed only very weak responses to indole, though 2methylindole did reach saturation.
The high-throughput screening of ~800 volatile compounds against the Olfr743 family allowed us to probe the prevalence of both agonism and antagonism for a much larger chemical space than the original diagnostic ligands. While this library is small compared to those typically found in drug screens (in which compounds can number in the millions), it is large compared to what has previously been reported in the olfactory literature and is approximately 25% as large as all the odorants reportedly described in public databases (~3100) [8] . We identified a total of 430 putative antagonists across the receptor family, of which 149 were specific to a single receptor, and the rest shared across multiple members. Clustering the pairwise correlations of the agonist and antagonist single-concentration data across the ~800 test compounds reflected the phylogenetic clustering of receptors, suggesting a link between sequence diversification and functional diversification.
Examining the top five inhibitors for each receptor in dose-response agonism and antagonism
experiments provided more precise and accurate measurements of potency and efficacy across the ten ORs. Both the degree of inhibition and OR-specificity were highly variable, in good agreement with the varied effects observed across groups of functionally segregated ex vivo 14 OSNs. Compounds not only elicited distinct ranges of activation or inhibition, but also opposite pharmacological outcome, switching from antagonism to agonism between receptors, effectively leading to lack of functional redundancy. This latter conclusion is in agreement with current views of functional diversification observed for OR paralog activation [51, 52] .
To further explore the relationship between phylogeny and function, we identified two sources of diversification in the experimental receptor responses. First, as sequence identity diverged, so did the binding specificity. Even phylogenetically closely related ORs, for which the sets of binders were most similar ( Figure S8D ), exhibited variable specificity, resulting in distinct molecular receptive ranges. Second, we observed an additional source of variability due to the pharmacological outcomes among paralogous ORs that recognized the same ligands but exhibited opposite responses (i.e. agonism vs. antagonism - Figure S8D ). Such distinction upon binding can arise through conformational changes that alter G protein affinity and selectivity, or transduction cascade efficiency [53] [54] [55] . This is also observed in OR allelic variability where minimal sequence alterations, often a single SNP, lay outside of presumptive OR binding pockets [56] , yet were responsible for dramatic shifts in pharmacological responses [21-23, 27, 28, 57]. Because the OR repertoire evolved along with speciation [58] , this functional diversification, and the extra degree of freedom contributed by antagonism, likely contributes to the OR neofunctionalization required for functional gene retention following OR gene duplication.
Our results suggest that antagonism is a prevalent feature of the peripheral olfactory system, and that its combinatorial nature mirrors that of agonism. We demonstrate extensive non-linear OR-mediated computation of mixture information prior to transmission of signal to the olfactory bulb. This was observed directly in calcium imaging experiments for two-component mixtures.
The in vitro dose-response data across all tested ligands and ORs was shown to be compatible with published models of competitive binding [29, 48-50] and consistent with the theoretically proposed case in which binding affinity was only weakly correlated with activation efficacy. The consequence is to increase the encoding capacity of the system by resisting OR ensemble saturation in the face of complex mixtures of odorants. This and the particular correlation structure of agonistic and antagonistic receptive ranges leads to a far richer mixture encoding logic for the system than one where antagonism is rare and responses are largely additive.
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METHOD DETAILS
Animal Care & Sources C57BL/6J male mice, aged 8 to 12 weeks, were obtained from the Jackson Laboratory. All experimental procedures were in compliance with NIH guidelines and were approved by the Mispro Biotech Services Institutional Animal Care and Use Committee.
Calcium Imaging
Tissue was prepared as described in Poivet et al., 2018 [59] . In brief, olfactory epithelia were placed into 5 mL L15 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco BRL, Grand Island, NY, USA), 0.5 U ml−1 collagenase,
St-Louis, MO, USA), and 50 μg ml−1 deoxyribonuclease II (Worthington Biochem).
The tissue was incubated at 37°C for 75 min on a rocker, subsequently dissociated by trituration with a siliconized pipette, and plated onto concanavalin-coated glass coverslips (Sigma-Aldrich, 
Cell line generation
A modified HEK293T cell line expressing the endogenous Rtp1 gene was generated for functional OR expression. A targeted insertion of the constitutively active CMV promoter (P CMV ) was performed using CRISPR/Cas9 technologies followed by homologous directed DNA repair For antagonist experiments, the EC 80 of indole was first determined in a duplicate doseresponse agonist experiment and then test compounds were diluted as before and mixed with a dilution of indole to achieve the EC 80 . In dose-response experiments in which both agonist and antagonist were varied, compounds were prepared as for the antagonist dose-response experiment but with indole diluted to range between 10 -8 and 10 -3 M at half-log intervals as well.
Cells were incubated with compound at 37°C in 5% CO2 for 30 minutes In the context of Golf, OR activity was monitored using the HTRF cAMP dynamic 2 kit (Cisbio, Cat # 62AM4PEB), a competitive immunoassay between native cAMP produced by cells and the cAMP tracer molecule, labeled with proprietary CisBio fluorophore D2. cAMP-D2 bound to the anti-cAMP mouse antibody labeled with cryptate generates fluorescence. The signal is expressed as fluorescence ratio of the emission wavelength at 665 nm to 620 nm. The HTRF assay plates were read on Pherastar (BMG labtech). Dose-response data were graphed in GraphPad Prism 7.04 to calculate EC 50 , relative IC 50 , Hill slopes, maxima and minima of the response signals, and to graph dose-response curves. Agonist dose-response experiments were carried out in duplicates. The standard errors of the mean were calculated and the data points were fitted to a four parameter non-linear regression following the Hill equation (unconstrained Hill slope).
High-Throughput Screening
The same transfection and analyses conditions were applied to the library screening as for the OR full dose-response curve described above. A library of 800 odorants sourced internally was assembled in 100% solvent (DMSO) at a stock concentration of 300 mM and stored at -20° C. Assay variability and reliability were evaluated by calculating the Z', a measure of the assay window and the standard deviations of minimum and maximum cAMP production per plate. The average Z' value obtained across all experiments was 0.86 (SD=0.03) and 0.70 (SD=0.09) for agonism and antagonism respectively, and surpassed minimal requirement above the standard quality limit of Z' > 0.5 [60] .
Receiver Operator Characteristic curves were further used to assess the accuracy of the single point screen to predict modulation at the dose-response level. All data points were considered for the Pearson correlation matrix analyses.
Competitive binding model with spontaneous receptor activity
We propose a model of competitive binding that includes spontaneous activation of the receptor as shown in Figure 7A . The on and off rates of the binding of ligand X i are denoted by κ + 1,i and κ -1,i respectively. Once bound, there is a rate of activation of the receptor, which depends on the bound ligand. If X i is the bound ligand, we denote its rate of activating the receptor as κ 2,i . The activated receptor reverts back to its native, unbound state with a rate ks, which can in turn 20 spontaneously activate with a rate k + s . The output of the experiment is assumed to be proportional to the total number of activated receptors. When the set of ligands X 1 , X 2, …, X K at concentrations C 1 , C 2, …, C K respectively are delivered, by writing down the set of coupled rate equations, we can calculate the total number of activated receptors of a particular type at steady state as
where the sums are from 1 to K, κ -1 i and η i are the binding affinity and activation efficacy respectively of ligand X i, η s is the constitutive activity of the receptor and a 1 and a 2 are constants.
In terms of the rate constants introduced previously, we have 
Fitting activation and inhibition profiles to the competitive binding model
To obtain the plots in Figure 7B where α is the ratio (η inhη s )/(η actη s ). Note there are three free parameters: κ inh, κ act and α. We obtain the best fit curves in Figure 7B by minimizing the RMSE between the CB model and the data from the competitive binding assay.
To obtain the values of the binding affinities in Figure 7C and D, we fit the CB model to the activation and inhibition profiles of 39 unique compounds delivered to the ten receptors from the Olfr743 family. For the activation assay, we first subtracted the HTRF ratio at the lowest concentration of the activator, which is equivalent to subtracting a 2 + a 1 η s from the equation for R. We fit the dose-response curves to the Hill function with Hill coefficient 1 (as predicted by the CB model). We collected the best-fit binding affinities for the receptor-ligand pair which show a significant positive activation of the receptor (std. dev of the HTRF ratio across the ten concentrations > 80 and positive best-fit saturation level) while excluding those which have a best-fit ln κ -1 > 8.5 ~ 200µM (since the tested concentrations do not exceed much beyond this value). The screening above yielded the binding affinities for 50 activators from a total of ~400 activation profiles. For the inhibition assay, the activator was indole delivered at EC 80 , calibrated from an activation assay performed on the same set of cells. We normalize the data similar to the analysis from the competitive binding assay. The normalized inhibition profiles are fit to the equation for R norm given above, where κ act is obtained from the activation assay for the activator and C act is the EC 80 . The best-fit binding affinities which show significant inhibition (std. dev of the HTRF ratio across the ten concentrations > 80, best-fit α value < 0.5, and best-fit ln κ -1 inh > 8.5) were collected, yielding the binding affinities for 149 inhibitors.
Note that the best-fit curves from the CB model yield the activation efficacy η in a continuum between 0 and 1. In practice, however, most profiles do not saturate and the best-fit η value is imprecise. In our dataset, we observed few partial agonists and thus we simplified our analysis by effectively projecting the activation efficacies into two broad categories: activators (η ≈ 1) and inhibitors (η ≈ 0).
Correlation between binding affinity and functional outcome
We calculated the Pearson correlation coefficient between the logarithm of the binding affinity and the binary variable activator/inhibitor. Using the expression for the correlation coefficient between a continuous and binary variable, we have
where is the empirical standard deviation of ln κ -1 (= 1.37), and f act is the probability that a compound that binds to a receptor is an activator. Using the data from the high-throughput screen of 800 odorants we estimated f act ~ 0.68 (444 total activators out of 653 total binders), which gives ρ = 0.18. To calculate the standard deviation of ρ, we repeat the entire analysis by first adding 6% noise to the dataset, where 6% is the average noise to signal ratio estimated from measurements of the HTRF ratio at the lowest concentration of each compound. The standard deviation of ρ is then computed to be the standard deviation of the re-calculated ρ values over 100 repetitions. Note that the correlation coefficient calculated here corresponds to the correlation between log-binding affinity and activation efficacy when the odorant and receptor are both independently drawn in each sample. One could instead calculate the correlation coefficient for each receptor, where the receptor is fixed and the correlation is calculated for sampled odorants. The latter would indeed contain more information about each receptor, but requires enough data to compute ρ for each receptor, which is not available with our current dataset.
To generate the plots in Figure 7E , we calculate the probability that a receptor is activated when an odorant mixture consisting of a particular number of ligands was delivered. We assume that the receptor-ligand interactions are independent across ligands, that if a ligand binds, it is either a perfect agonist (η = 1) or a perfect inhibitor (η = 0) and that each ligand is equiproportionate and delivered at saturating concentrations (the normalization effect is even stronger at weaker, where the sum is over the ligands in the mixture. If η mix > f act , the receptor is considered active.
The sparsity for a fixed mixture complexity K is defined as the probability that η mix > f act over many samples of mixtures with K ligands. To obtain the sparsity vs K for other values of ρ as shown in Figure 7E , we tune the value of M act accordingly.
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QUANTIFICATION AND STATISTICAL ANALYSIS
Calcium Imaging Analysis
Images To estimate the number of unique odor responsive groups, the odorant responses by each cell were arranged into a binary array such that 0 indicated no response, while 1 represented a validated response to that odorant. Any cells that responded inconsistently to the same odorant were rejected from further analysis. The pattern of activation for each cell allowed for classification into distinct groups. All such cell activation patterns were fed into a classifier in a 24 randomized order. The emergence of new groups and the growth of previously seen groups were tracked and fed through a rarefaction analysis protocol (iNEXT R package, [61] ). This allowed for the estimation of the expected total amount of groups, based on the abundance and growth rates of the already identified activation patterns.
Cells that have been validated as "good cells" were fed into a Modulation Analysis tool, custom Figure S4 ) were tested at a range of concentrations with a diagnostic panel of ligands. In the resulting heat map blue and red hue represent the calculated EC50 and IC50 for agonism and inverse agonism, respectively. Activation efficacy is represented by the diameter of the circle. Absence of a circle indicates absence of activation or inverse agonism but does not exclude neutral antagonism. True Positive Rate (Sensitivity) Figure S7 . Statistical Receiver Operator Characteristic (ROC) analysis. ROC curves demonstrate that both primary activation and inhibition screens were able to predict whether compounds would pass an activation or inhibition dose response experiment. The optimal threshold, determined as the closest point to the upper left corner, was 32% for activation and 24% for inhibition. Confidence interval for the threshold is shown in gray. AUC = area under the curve. 
